Cybeats Announces Participation in Upcoming RSA Conference
Toronto, Ontario--(Newsfile Corp. - May 31, 2022) - Scryb Inc. (CSE: SCYB) (OTCQB: SCYRF) (FSE: EIY) ("Scryb'' or the "Company"), is pleased...
Month: May 2022
CONMED Corporation Announces Private Offering of $600 Million of Convertible Senior Notes
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it intends to offer, subject to market conditions and other factors,...
SummaForte(TM) Adds All-Natural Sleep Aid SummaRest(TM) to Its Lineup of Innovative Performance and Recovery Products
Bloomington, Indiana--(Newsfile Corp. - May 31, 2022) - SummaForte has added a fast-acting, all-natural sleep aid to its innovative, best-selling...
St. Peter’s Health Moves to the Innovaccer Health Cloud to Optimize Care Management and Collaboration Across Care Sites
Regional integrated health system chooses the Innovaccer 2022 Best in KLAS data platform to provide solutions for enhanced provider-patient collaboration...
Melzi Surgical to Present at the Virtual Investor Innovations in MedTech Event
Live video webcast with moderated roundtable with members of the Melzi leadership team and surgical Key Opinion Leaders on Wednesday,...
Imaging Biometrics Submits FDA 510(k) Application for IB Zero G
Patented Artificial Intelligence Technology Eliminates the Need for Gadolinium-Based Contrast Agents in MRI ExamsMILWAUKEE, WI / ACCESSWIRE / May 31,...
DEA Delays MMJ Clinical Trials Yet Black Market Thrives
DEA Marijuana Neglect Expose By Mariana Van ZellerPROVIDENCE, RI / ACCESSWIRE / May 31, 2022 / MMJ International Holdings:https://pr.report/fMXWtDNlAs states...
Paxman Celebrates Five Years of Increasing Access to Scalp Cooling at Asco 2022
CHICAGO, IL / ACCESSWIRE / May 31, 2022 / Paxman will be thanking partners from across the Oncology speciality for...
Altamira Therapeutics Announces Marketing Approval for Bentrio Nasal Spray in Indonesia
HAMILTON, BERMUDA / ACCESSWIRE / May 31, 2022 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that...
First Subject Dosed in Lipigon’s Phase I Clinical Study with Antisense Oligonucleotide Candidate Derived from Secarna Pharmaceutical’s LNAplus(TM) Technology Platform
First antisense oligonucleotide (ASO) derived from Secarna's LNAplus™ technology platform to enter the clinic after a series of successful pre-clinical...
Novamind Reports Fiscal Q3 2022 Financial Results and Operating Highlights
Record high quarterly revenue of $3,227,352, +32% over the previous quarterGrowth driven by Arizona acquisition, expanding clinic network to eight...
Health Advance Introduces the President of its CBD Wine Beverage Brand, 66° Beverage Company
Proprietary CBD Infusion Techniques Creating Unique Adult Lifestyle Beverage RangeNEW YORK, NY / ACCESSWIRE / May 31, 2022 / Health...
Mapi Pharma to Present Late Breaking Poster Presentation on GA Depot for Treating Primary Progressive Forms of Multiple Sclerosis at CMSC 2022 Annual Meeting
Interim analysis of Phase IIa study of GA Depot in PPMS will be presentedNESS ZIONA, Israel, May 31, 2022 (GLOBE...
Optimi Health Enters Into Psilocybin Supply Agreement With Filament Health
Collaborative expertise a hallmark for future supply of natural psilocybin Optimi Health EU-GMP Facilities Optimi's 20,000 square foot EU-GMP cultivation...
Biora Therapeutics Shares Presentation of Patient Data Establishing Correlation Between Drug Levels in Colon and Patient Outcomes in Ulcerative Colitis
Oral Presentation Delivered at DDW 2022 Informs Clinical Study Design for Biora’s Targeted Therapeutics PlatformSAN DIEGO, May 31, 2022 (GLOBE...
Silk Road Medical Extends Cash Runway by Securing up to $250 Million in Debt Financing
SUNNYVALE, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Company) (Nasdaq: SILK), a company focused on reducing...
Y-mAbs Announces FDA Acceptance of Biologics License Application for OMBLASTYS® (omburtamab) for the Treatment of Neuroblastoma for Priority Review
NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical...
BioCorRx to Present at the LD Micro Invitational XII on June 7th
ANAHEIM, CA, May 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of...
Clover Doses First Participants in Phase 1 Trial with SCB-2020S, a Potentially Broadly Protective Chimeric COVID-19 Vaccine Candidate
--Phase 1 clinical trial will evaluate safety and immunogenicity of several formulations of SCB-2020S as a 2-dose vaccination series in...
Pure Extracts Receives 3 New Listings from the Ontario Cannabis Store
VANCOUVER, British Columbia., May 31, 2022 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...